China Universal Asset Management Co., Ltd. Autolus Therapeutics PLC Transaction History
China Universal Asset Management Co., Ltd.
- $893 Million
- Q3 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Autolus Therapeutics PLC stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 38,393 shares of AUTL stock, worth $87,919. This represents 0.02% of its overall portfolio holdings.
Number of Shares
38,393
Previous 23,434
63.83%
Holding current value
$87,919
Previous $81,000
71.6%
% of portfolio
0.02%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding AUTL
# of Institutions
104Shares Held
163MCall Options Held
2.8KPut Options Held
13.4K-
Wellington Management Group LLP Boston, MA24.2MShares$55.5 Million0.02% of portfolio
-
Blackstone Inc New York, NY20.5MShares$46.9 Million0.35% of portfolio
-
Syncona Portfolio LTD Guernsey, Channel Islands, X018.6MShares$42.5 Million83.42% of portfolio
-
Deep Track Capital, LP Greenwich, CT15.3MShares$35 Million2.04% of portfolio
-
Avoro Capital Advisors LLC New York, NY12.3MShares$28.3 Million0.67% of portfolio
About Autolus Therapeutics plc
- Ticker AUTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 90,909,800
- Market Cap $208M
- Description
- Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...